6 Top Companies That Destroyed Shareholders Last Week
Although stocks now are beginning to make a comeback, there are still some that are slowing this recovery and punishing their shareholders.
All Work
Chris Lange
Analysts Much More Excited About Finisar After Solid Earnings
Analysts and investors alike were thrilled with Finisar's fiscal third-quarter financial results and pushed the stock up nearly 20% on Friday.
Finisar Wows With Guidance
Finisar reported mixed fiscal third-quarter financial results after the markets closed on Thursday.
3M Partners Up With Nobel
3M will collaborate with Nobel Media over several years to bring light to important global issues, like the future of scientific education and sustainability.
Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) scored a win in a late-stage trial for the treatment of rheumatoid arthritis (RA). The company, in conjunction with Sanofi, announced that a Phase 3 monotherapy study met its…
SEC Charges Tech Company With Misleading Investors
The SEC has announced that a developer of technologies for touchscreen devices has agreed to pay $750,000 to settle charges that it misled investors.
SEC Settles Charges With Inside Trader
The SEC has announced that it has agreed to settle enforcement actions against a Florida man trading on inside information ahead of a pharmaceutical company merger.
Corvus Pharma Releases Expected Pricing Range in IPO
Corvus Pharmaceuticals expects to price more than 4 million shares in the range of $15 to $17 apiece in an initial public offering valued up to nearly $92 million.
SEC Charges California Water District for Misleading Investors
The SEC recently charged California’s largest agricultural water district, Westlands Water District, for misleading investors regarding its financial condition as it issued a $77 million bond offering.
El Pollo Loco Chokes on Guidance
El Pollo Loco Holdings, Inc. (NASDAQ: LOCO) reported fourth quarter financial results after markets closed on Thursday. The company had $0.15 in earnings per share (EPS) on $86 million in revenue compared to consensus…
Ulta Stuns Investors With Amazing Earnings and Guidance
Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) released its fourth-quarter earnings report after markets closed on Thursday. The company had $1.69 in earnings per share (EPS) on $1.27 billion in revenue compared to…
SEC Returns Investor Funds From Unregistered Broker
The SEC has announced that a Cyprus-based company has agreed to pay $11 million to settle charges that it illegally sold binary options to U.S. investors.
SEC Issues Charges Against Unregistered Fund Manager
The SEC has announced fraud charges against an unregistered fund manager accused of hiding his checkered past while providing false and misleading data to investors and an independent research firm.
Nuance Communications Agrees to Buyback From Icahn
Nuance Communications has announced that it has agreed to repurchase $500 million worth of shares of its common stock from Carl Icahn and some of his affiliates.
Canadian Solar Stumbles Over Guidance
Canadian Solar reported better-than-expected fourth-quarter financial results before the markets opened on Thursday.
Box Stuns Investors Despite Q4 Loss
Box released a better-than-expected fiscal fourth-quarter earnings report after the markets closed on Wednesday.
Why Investors Love Dollar General Earnings
Dollar General reported mixed fiscal fourth-quarter financial results before the markets opened on Thursday.
Social Media Short Interest Remains Mixed
The February 29 short interest data have been compared with the previous report, and short interest was mixed in these selected social media stocks.
Short Sellers Become More Selective in Cybersecurity
The February 29 short interest data have been compared with the previous figures, and short interest for the selected cybersecurity stocks was mixed.
Major Pharma Short Interest Takes a Small Step Back
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.